Data gathered: November 30
Alternative Data for Veru
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 69 | Sign up | Sign up | Sign up |
| Webpage traffic | 17,000 | Sign up | Sign up | Sign up |
| Google Trends | 63 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 143 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 19,147 | Sign up | Sign up | Sign up |
| Twitter Followers | 899 | Sign up | Sign up | Sign up |
| Twitter Mentions | 14 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 28 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 51 | Sign up | Sign up | Sign up |
About Veru
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS).
| Price | $0.71 |
| Target Price | Sign up |
| Volume | 582,060 |
| Market Cap | $107M |
| Year Range | $0.56 - $1.79 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia and Wasting DisordersNovember 26 - Finnhub |
|
 |
Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting DisordersNovember 25 - Yahoo |
 |
Veru’s (VERU) Outperform Rating Reiterated at OppenheimerNovember 8 - ETF Daily News |
|
Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeekNovember 4 - Yahoo |
Warning: VERU is at high risk of performing badlyOctober 27 - Seeking Alpha |
|
 |
Veru (NASDAQ:VERU) Stock Crosses Below 200 Day Moving Average - Should You Sell?October 22 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 4M | 10M | 1.3M | -11M | -11M | -0.070 |
| Q1 '24 | 4.1M | 3.5M | 680,000 | -10M | -9.6M | -0.080 |
| Q4 '23 | 2.1M | 990,000 | 1.2M | -8.3M | 0 | -0.080 |
| Q3 '23 | 3.9M | 2.3M | 1.5M | -11M | -10M | -0.120 |
| Q2 '23 | 3.3M | 2.1M | 1.2M | -13M | -5.9M | -0.130 |
Insider Transactions View All
| BARNETTE K GARY filed to buy 5,000 shares at $1.3. May 24 '24 |
| FISCH HARRY filed to buy 774,736 shares at $1.3. May 28 '24 |
| STEINER MITCHELL SHUSTER filed to sell 6,942,709 shares at $1.2. May 24 '24 |
| STEINER MITCHELL SHUSTER filed to sell 7,006,088 shares at $1.4. May 24 '24 |
| STEINER MITCHELL SHUSTER filed to sell 7,006,388 shares at $1.4. May 24 '24 |
Similar companies
Read more about Veru (VERU) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Veru?
The Market Cap of Veru is $107M.
What is the current stock price of Veru?
Currently, the price of one share of Veru stock is $0.71.
How can I analyze the VERU stock price chart for investment decisions?
The VERU stock price chart above provides a comprehensive visual representation of Veru's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Veru shares. Our platform offers an up-to-date VERU stock price chart, along with technical data analysis and alternative data insights.
Does VERU offer dividends to its shareholders?
As of our latest update, Veru (VERU) does not offer dividends to its shareholders. Investors interested in Veru should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Veru?
Some of the similar stocks of Veru are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.